SeaStar Medical Holding (ICU) Non Operating Income (2024 - 2026)
SeaStar Medical Holding's (ICU) quarterly Non Operating Income came in at $85000.0 in Q1 2026, up 60.38% YoY from $53000.0 in Q1 2025, and up 134.84% on a QoQ basis from -$244000.0 in Q4 2025.
SeaStar Medical Holding (ICU) Non Operating Income (2024 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 3 years of Non Operating Income data on file, last reported at $85000.0 in Q1 2026.
- Quarterly Non Operating Income rose 60.38% year-over-year to $85000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1000.0 (changed N/A YoY) and the FY2025 annual result came in at $28000.0, up 100.4% from the prior year.
- Non Operating Income grew to $85000.0 in Q1 2026, from -$244000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $348000.0 in Q4 2024 to a low of -$244000.0 in Q4 2025.
- A 3-year average of $54500.0 and a median of $69000.0 in 2025 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 586.36% in 2025, down 170.11% in 2025.
- Tracing ICU's Non Operating Income over 3 years: stood at $348000.0 in 2024, then tumbled by 170.11% to -$244000.0 in 2025, then jumped by 134.84% to $85000.0 in 2026.
- The last three Non Operating Income figures came in at $85000.0 (Q1 2026), -$244000.0 (Q4 2025), and $107000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 61,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61,000.00 |
| Mar 31, 2026 | 85,000.00 |
| Dec 31, 2025 | -244,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Dec 31, 2024 | 348,000.00 |
| Sep 30, 2024 | -22,000.00 |